000 | 01956 a2200577 4500 | ||
---|---|---|---|
005 | 20250516232016.0 | ||
264 | 0 | _c20150514 | |
008 | 201505s 0 0 eng d | ||
022 | _a2314-6141 | ||
024 | 7 |
_a10.1155/2014/529186 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFang, Dong | |
245 | 0 | 0 |
_aNomogram predicting renal insufficiency after nephroureterectomy for upper tract urothelial carcinoma in the Chinese population: exclusion of ineligible candidates for adjuvant chemotherapy. _h[electronic resource] |
260 |
_bBioMed research international _c2014 |
||
300 |
_a529186 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAge Distribution |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aChemoradiotherapy, Adjuvant _xstatistics & numerical data |
650 | 0 | 4 |
_aChina _xepidemiology |
650 | 0 | 4 |
_aCisplatin _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 |
_aKidney Neoplasms _xepidemiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNephrectomy _xstatistics & numerical data |
650 | 0 | 4 | _aNomograms |
650 | 0 | 4 | _aPatient Selection |
650 | 0 | 4 |
_aPostoperative Complications _xepidemiology |
650 | 0 | 4 |
_aRenal Insufficiency _xepidemiology |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aSensitivity and Specificity |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aZhang, Qifu | |
700 | 1 | _aLi, Xuesong | |
700 | 1 | _aQian, Cheng | |
700 | 1 | _aXiong, Gengyan | |
700 | 1 | _aZhang, Lei | |
700 | 1 | _aChen, Xiaopeng | |
700 | 1 | _aZhang, Xiaoyu | |
700 | 1 | _aYu, Wei | |
700 | 1 | _aHe, Zhisong | |
700 | 1 | _aZhou, Liqun | |
773 | 0 |
_tBioMed research international _gvol. 2014 _gp. 529186 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1155/2014/529186 _zAvailable from publisher's website |
999 |
_c24151719 _d24151719 |